Frequency of individuals with skewed TCR BV repertoire in PNH and control groups as determined by the three-criteria analysis3-151
TCR family . | Controls3-150 (%) . | PNH patients (%) . | P value . |
---|---|---|---|
BV1 | 19 | 27 | NS |
BV2 | 7 | 11 | NS |
BV3 | 17 | 32 | NS |
BV4 | 0 | 29 | 0.04 |
BV5 | 6 | 16 | NS |
BV6 | 13 | 15 | NS |
BV7 | 0 | 44 | 0.003 |
BV8 | 22 | 28 | NS |
BV9 | 17 | 42 | NS |
BV11 | 17 | 29 | NS |
BV12 | 8 | 46 | NS |
BV13 | 6 | 28 | NS |
BV14 | 6 | 24 | NS |
BV15 | 40 | 26 | NS |
BV16 | 13 | 37 | NS |
BV17 | 11 | 26 | NS |
BV18 | 12 | 29 | NS |
BV21 | 22 | 38 | NS |
BV22 | 7 | 29 | NS |
BV23 | 0 | 40 | 0.02 |
BV24 | 0 | 38 | 0.04 |
TCR family . | Controls3-150 (%) . | PNH patients (%) . | P value . |
---|---|---|---|
BV1 | 19 | 27 | NS |
BV2 | 7 | 11 | NS |
BV3 | 17 | 32 | NS |
BV4 | 0 | 29 | 0.04 |
BV5 | 6 | 16 | NS |
BV6 | 13 | 15 | NS |
BV7 | 0 | 44 | 0.003 |
BV8 | 22 | 28 | NS |
BV9 | 17 | 42 | NS |
BV11 | 17 | 29 | NS |
BV12 | 8 | 46 | NS |
BV13 | 6 | 28 | NS |
BV14 | 6 | 24 | NS |
BV15 | 40 | 26 | NS |
BV16 | 13 | 37 | NS |
BV17 | 11 | 26 | NS |
BV18 | 12 | 29 | NS |
BV21 | 22 | 38 | NS |
BV22 | 7 | 29 | NS |
BV23 | 0 | 40 | 0.02 |
BV24 | 0 | 38 | 0.04 |